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Background: The aim of this study was to investigate the effect of C-reactive protein/oxidised low-density
lipoprotein/β2-glycoprotein I (CRP/oxLDL/β2GPI) complex on atherosclerosis (AS) in diabetic BALB/c mice.
Methods: BALB/c mice were fed high-fat and normal diet. Eight weeks later, the mice fed with high-fat diet were
injected with streptozotocin (STZ) to induce diabetes. The diabetic mice were respectively injected twice monthly
with 20 μg oxLDL, 20 μg β2GPI, 40 μg oxLDL/β2GPI complex, 44 μg CRP/oxLDL/β2GPI complex, and PBS. Aortas
were stained with Sudan IV to investigate lipid plaque formation. The infiltration condition of smooth muscle cells
(SMCs), macrophages, and T cells in the aortas were determined by immunohistochemistry (IH). The mRNA
expressions of receptors associated with lipid metabolism were quantified by real-time PCR. The phosphorylation of
p38 mitogen-activated protein kinase (p38MAPK) and MKK3/6 in aorta tissues were assessed by Western blot.
The expression of inflammation cytokines was evaluated by protein chip.
Results: The lipid plaques were more extensive, the lumen area was obviously narrower, the ratio of intima and
media thickness were increased, and the normal internal elastic lamia structure and endothelial cell disappeared
(P < 0.05) in the oxLDL and CRP/oxLDL/β2GPI groups (P < 0.05). CRP/oxLDL/β2GPI complex dramatically promoted
infiltration of SMCs, macrophages, and T cells, improved the mRNA expression of ABCA1 and ABCG1, but reduced
the mRNA expression of SR-BI and CD36 and increased the phosphorylation of p38MAPK and MKK3/6 (all P < 0.05). The
highest expression levels of IL-1, IL-9, PF-4, bFGF, and IGF-II were detected in the CRP/oxLDL/β2GPI group (P < 0.05).
Conclusions: CRP/oxLDL/β2GPI complex aggravated AS in diabetic BALB/c mice by increasing lipid uptake,
the mechanism of which may be mediated by the p38MAPK signal pathway.
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Atherosclerosis (AS) is the main etiology of diabetic
macroangiopathy and the leading cause of disability and
death of patients with diabetes mellitus [1]. Diabetic pa-
tients with cardiovascular diseases (CVD) possess more
diffused AS lesions with more severe degrees compared
with other CVD patients [2,3], suggesting that diabetic AS
has a unique pathogenic mechanism. β2-glycoproteinI
(β2GPI), a highly glycosylated plasma protein with an ap-
proximate molecular weight of 50 kDa, was found to be
the main antigen in the serum of anti-phospholipid syn-
drome (APS) patients [4]. Β2GPI interacts with oxidised
low density lipoprotein (oxLDL) via 7-ketocholesterol hav-
ing an w-carboxyl acyl chain, producing stable and non-
dissociable oxLDL/β2GPI complexes [5], which could
further interacts with C-reactive protein (CRP), producing
CRP/oxLDL/β2GPI complex [6]. Recent studies have dem-
onstrated that β2GPI complexes (oxLDL/β2GPI and CRP/
oxLDL/β2GPI) have a close relationship with AS [6,7]. Re-
search has demonstrated that the levels of oxLDL/β2GPI
and CRP/oxLDL/β2GPI complexes in the serum of dia-
betic patients were obviously higher than those of the nor-
mal control [6]. The amounts of these complexes have
been found in AS plaque tissues using immunohistochem-
istry, indicating that β2GPI complexes have an important
function in AS development [6,7]. In addition, Matsuura
et al. discovered that the CRP/oxLDL/β2GPI complex was
significantly elevated only in diabetic AS patients [7], indi-
cating that this complex is specific to diabetic AS but the
pathogenic mechanism is not clear. Thus, this studyFigure 1 Body weight of DM group and NC group. ●, DM group (n=12
Maintained on high-fat and sugar diet and standard chow diet, respectivel
weeks later, DM group was intraperitoneally injected with 80 mg/kg 2% ST
was measured 72 h after the injection, and those with blood glucose ≥16.7
simultaneously injected with sodium citrate buffer. Two weeks later, the DM
complex 40 μg, CRP/oxLDL/β2GPI complex 44 μg, and PBS, after which the
β2GPI group, CRP/oxLDL/β2GPI group, and PBS group, respectively (each g
NC group were injected with PBS at the same time. Four weeks later, bloo
cervical dislocation.further explored the effect of CRP/oxLDL/β2GPI complex
on AS occurrence and on the development of diabetic
mice through in vivo research and the possible pathogenic
mechanism.Results
Blood glucose and body weight
After STZ injection, the mice in the DM group all became
diabetic, but no animal died until they were sacrificed.
After the mice were fed with high-fat and sugar diet for
eight weeks, the body weight of the DM group became no-
ticeably higher, which was different from that of group NC
(P<0.05). The DM group significantly lost weight after STZ
injection for three weeks compared with the NC group
(P<0.05), then gradually gained weight because of continu-
ous subsistence on high-fat diet (Figure 1). The blood glu-
cose of the DM group was three times higher than that of
the NC group (P<0.01).Plasma lipid level of diabetic BALB/c mice
Plasma triglycerol (TG) and total cholesterol (TC) levels
were higher in DM group than in NC group. The TC
levels of oxLDL, CRP/oxLDL/β2GPI, and PBS groups
were higher than those of NC group (P< 0.05), whereas
the TG level did not exhibit significant difference in all
the DM groups (Figure 2). The β2GPI and oxLDL/
β2GPI groups showed decreased levels of plasma TG
and TC.0); ■, NC group (n=24). *P < 0.05, compared with group NC.
y, mice in DM group and NC group were weighed every week. Eight
Z three times for three consecutive days. The tail vein blood glucose
mmol/L were considered DM mice. The NC group was
group was treated with oxLDL 20 μg, β2GPI 20 μg, oxLDL/β2GPI
y were randomly divided into oxLDL group, β2GPI group, oxLDL/
roup n=24). The same interventions were boosted four weeks later.
d was obtained via retro-orbital plexus and then sacrificed by
Figure 2 Plasma lipid level of the DM group significantly increased. *P < 0.05, compared to group NC.
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plaque in aortas
Pale yellow wax-like hills were spread along the aortic in-
tima of the DM group, which were lined with lipid streak
and atherosclerotic plaque. The entire aortic intima was
uneven with a stiff wall. Tissues of the DM group seemed
crisper and more difficult to extend, except those in the
PBS group. Among all the DM groups, PBS group pos-
sessed the least lipid deposits, whereas CRP/oxLDL/β2GPI
group exhibited relatively obvious AS plaques, ranking sec-
ond to the oxLDL group (Figure 3A). As seen in Figure 3B,
the lesion in the CRP/oxLDL/β2GPI group was about 2.4-
fold that of the β2GPI group (P<0.05), 1.66-fold that of
the oxLDL/β2GPI group (P<0.05), and 6-fold that of the
PBS group (P<0.05).CRP/oxLDL/β2GPI increases intima/media thickness value
in aortas
H&E stained cross-sections at the root of the aortas
showed different extents of damage in the DM group. Only
the internal elastic lamina of the PBS group remained al-
most intact with minimal intima proliferation. However,
the structure of the intima in the other DM groups seemed
disordered, with intima proliferation and media atrophy.
Moreover, almost no normal structure was observed in the
CRP/oxLDL/β2GPI group. Endothelial cells fell off and the
normal structure of the internal elastic lamina disappeared
(Figure 3C). As seen in Figure 3D, ratios of intima/media
thickness (IMT, thickness of intima and media were mea-
sured at the thickest part of the plaques) of the oxLDL
group and the CRP/oxLDL/β2GPI group remarkably in-
creased (P < 0.05).CRP/oxLDL/β2GPI promotes the infiltration of SMCs,
macrophages and T cells in the intima of aortas
CRP/oxLDL/β2GPI group showed strong positive expres-
sion of α-SMA in each layer of aorta. The other DM
groups only displayed positive expression on the surface
of the intima, not on the shrink media or not as strong as
that in the CRP/oxLDL/β2GPI group (Figure 4A). CRP/
oxLDL/β2GPI group showed remarkable positive areas
of macrophages (Figure 4B). T cell expression was not as
obvious as those of SMC and macrophages, but certain
amounts of T cells were found in the lumen in the CRP/
oxLDL/β2GPI group. Moreover, positive CD3 expression
was not limited to the intima, but was also found on the
adventitia (Figure 4C). Using Image Pro-Plus 6.0, the α-
SMA, MAC, and CD3 positive expressions of AS lesion in
the CRP/oxLDL/β2GPI group were found to be 1.925,
7.025, and 0.8025, respectively, which were higher than
those in other DM groups (P<0.05). By contrast, the ex-
pressions of the three kinds of cells in the PBS group were
much less than those of the others (Figure 4D).CRP/oxLDL/β2GPI increases ABCA1 and ABCG1expressions
and decreases CD36 and SRBI expressions in aortas
Real-time PCR results showed that the PBS and NC groups
seemed to share the same relative expression level of all the
target mRNAs. The other DM groups presented the oppo-
site tendency, with significantly up-regulated mRNA level
of ATP-binding cassette transporter protein A1 (ABCA1)
and ATP-binding cassette transporter protein G1 (ABCG1)
(Figure 5A) and down-regulated CD36 mRNA expression
level (Figure 5B). The CRP/oxLDL/β2GPI group obviously
promoted ABCG-1 mRNA expression and suppressed
Figure 3 Histological quantitation of the AS lesion in aortas. After induction of diabetes and treatment with 20 μg oxLDL, 20 μg β2GPI,
40 μg oxLDL/β2GPI complex, 44 μg CRP/oxLDL/β2GPI complex and PBS (as described in the Methods section), aortas were removed,
longitudinally cut open,stained with Sudan IV, or paraffin-embedded, sectioned, deparaffinated and then stained with haematoxylin and eosin.
The quantitation of the AS lesion and intima thickness were measured using Image Pro-Plus 6.0. The percentage of the plaque area to the total
aorta area and the ratios of intima/media thickness of lesions at the aortic roots were calculated. Results are shown as means ± SEM.
A: Representative images of Sudan IV stain(4×). B: Percentage of plaque area to total aorta area (n=4 mice per group). *P < 0.05, compared with
the CRP/oxLDL/β2GPI group, †P < 0.05, compared with the PBS group. C: Representative H&E stain at the root of the aortas, 200× magnification.
D: The ratios of intima/media thickness of lesions at the aortic roots (n=4). *P < 0.05, compared with the CRP/oxLDL/β2GPI group, †P < 0.05,
compared with the PBS group.
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(P<0.05). However, scavenger receptor type B1 (SR-BI)
mRNA expression of the CRP/oxLDL/β2GPI group was
almost the same as that of the PBS and NC groups, with
remarkably depressed SR-BI compared with the other DM
groups (P < 0.05) (Figure 5B).CRP/oxLDL/β2-GPI increases phosphorylation of p38MAPK
and MKK 3/6 expressions in aortas
As shown in Figure 6, the CRP/oxLDL/β2GPI group
significantly triggered the phosphorylation level of
p38MAPK and MKK 3/6 (P < 0.05) to a greater extent
compared with the other groups. Unlike CRP/oxLDL/
Figure 4 (See legend on next page.)
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Figure 4 Effect of CRP/oxLDL/β2-GPI on infiltration of inflammatory cells in the aortas. Aortas were removed, paraffin-embedded,
deparaffinated, underwent antigen retrieval, blocked, and then incubated with primary antibodies (Mac 1:200 or α- SMA 1:100 or CD3 1:100) at
4°C overnight. Biotinylated secondary antibody (1:200) was added, followed by HRP-labeled streptavidin incubation. Infiltrations of macrophages,
SMCs and T cells in the aortas were quantified as the percentage of the luminal surface covered by positive cells to the plaque area using Image
Pro-Plus 6.0. Results are shown as means ± SEM. A: Infiltration of SMCs in the aortas, 400× magnification. B: Infiltration of macrophages in the
aortas, 400× magnification. C: Infiltration of T cells in aortas, 400× magnification. D: Positive expressions of SMA, MAC and CD3 (n=4), expressed
as the percentage to plaque area. *P <0.05, compared with the CRP/oxLDL/β2GPI group, †P < 0.05, compared with the PBS group.
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on p38MAPK phosphorylation with PBS.
CRP/oxLDL/β2GPI increases bFGF, IGF-α, IL-1α, IL-9 and
PF-4 activation in aortas
The mice protein antibody chip detected 24 kinds of
cytokines. Each cytokine was represented by duplicate
spots, as seen in Table 1. According to the chemilumi-
nescence results, five cytokines were detected (Figure 7A)
as follows: basic fibroblast growth factor (bFGF), insulin-
like growth factor α (IGF-α), IL-1α, IL-9, and platelet
factor-4 (PF-4). Among them, PF-4 was the most pre-
dominant. Values were obtained using LabWorks soft-
ware. These five cytokines were induced to higher levels
in the oxLDL/β2GPI group, ranking second to the CRP/
oxLDL/β2GPI group (Table 2 and Figure 7B). Average light
intensity was normalised without background for each pair
of cytokine spots detected using Image Pro-Plus software.
Results were represented as bars (n = 3 mice per group).
Discussion
CVD is a leading cause of the mortality in diabetic pa-
tients, and its remarkable pathological change is AS.
Given the recent study of β2GPI complexes, the presentFigure 5 Effect of CRP/oxLDL/β2GPI on receptors associated with lipi
diabetes and treatment with oxLDL, β2GPI, oxLDL/β2GPI complex, CRP/oxL
aortas were removed and the expression of selected genes was measured
obtained by densitometry using the Quantity One analysis software packag
actin in the normal (non-diabetes) group. A: ABCA1 mRNA and ABCG1 mR
expression level in the aortas. Expression level of NC group was normalized
< 0.05, compared with the PBS group, ‡P< 0.05, compared with the NC grostudy explored the role of β2GPI complexes on AS in
the STZ-induced diabetic AS model.
This study successfully developed an animal model
that acquired the properties of diabetic AS, that was
higher blood sugar level, lipid level and intuitive lesion
staining with Sudan IV, after atherogenic diet for 19
weeks and STZ injection.
Increased intima-media thickness (IMT) reflects car-
diovascular risk, and its increasing value (at or above 1
mm) represents increased risk of myocardial infarction
and/or cerebrovascular disease [8]. Our results, demon-
strated that CRP/oxLDL/β2GPI treatment aggravated lipid
deposition, increased IMT value in STZ-induced diabetic
AS, promoted AS development and the risk of CVD.
Macrophages, SMCs and T cells have been considered
to be the key cells involved in AS lesion development.
Macrophages evolve into foam cells after amounts of lipid
uptake and finally leading to early fatty streak formation.
T cells, the main cells in cellular immunity, reach intima
at an early stage of AS formation. Activated T cells pro-
duce cytokines, taking part in regulating lesion formation
[9]. Meanwhile, As atherosclerosis progresses, vascular
SMCs are in proximity to and physically interact with in-
flammatory cell types, e.g. monocytes and macrophages,d metabolism gene expression in the aortas. After induction of
DL/β2GPI complex and PBS (as described in the Methods section),
using real-time PCR. Estimates of the quantity of the PCR product were
e. Results are show as means ± SEM of mRNA level normalized to β-
NA expression level in the aortas. B: CD36 mRNA and SR-BI mRNA
as 1, n= 4. *P < 0.05, compared with the CRP/oxLDL/β2GPI group, †P
up.
Figure 6 Effects of CRP/oxLDL/β2GPI on P38MAPK-associated signaling in the aortas. Extracts of aortas from NC and diabetes animals were
subjected to Western blots using the anti-bodies shown. A: Phosphorylation level of p38MAPK in aortas, expressed as the ratio to NC group
(expression level of NC group was normalized as 1, n= 4). *P < 0.05, compared with the CRP/oxLDL/β2GPI group, †P < 0.05, compared with the
PBS group, ‡P< 0.05, compared with the NC group. B: Phosphorylation level of MKK3/6 in aortas, expressed as the ratio to NC group (expression
level of NC group was normalized as 1, n= 4). *P < 0.05, compared with the CRP/oxLDL/β2GPI group, †P < 0.05, compared with the PBS group,
‡P< 0.05, compared with the NC group.
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the disease [10]. Furthermore, histological images have
shown that prior to the onset of complex plaque develop-
ment in human tissues [11,12] and experimental models
of atherosclerosis, markers of inflammation are observed
in SMCs in the media of the vessel wall, such as VCAM-1
and inflammatory transcriptional mediators, such as acti-
vated NF-κB [13,14].
Immunohistochemistry results confirmed stronger pos-
itive expressions and more infiltration of SMCs, macro-
phages and T cells along the intima of aortas in DM
groups, especially after being treated with CRP/oxLDL/
β2GPI.
Although much of the researches on atherosclerosis
has focused on the intimal accumulation of lipids and
inflammatory cells, there is an increasing amount of
interest in the role of the adventitia in coordinating the
immune response in atherosclerosis [15]. From the T
cells and macrophage stain results (Figure 4), we found
parts of positive expressions in the intima and in the
adventitia in CRP/oxLDL/β2GPI group, but not in theTable 1 Cytokines locations on the protein chip
A B C D
1 POS1 POS2 POS3 NEG
2 POS1 POS2 POS3 NEG
3 G-CSF GM-CSF IFN-γ IGF-II
4 G -CSF GM-CSF IFN-γ IGF-II
5 IL-13 IL-6 IL-9 Leptin
6 IL-13 IL-6 IL-9 Leptin
7 TIMP-1 TIMP-2 TNFα Thrombopoietin
8 TIMP-1 TIMP-2 TNFα Thrombopoietin
POS: positive control, NEG: negative control.other groups. Research has found that adventitia inflam-
matory cell infiltration occurs earlier than AS lesion for-
mation [15], which indicating CRP/oxLDL/β2GPI could
cause an early changes detected in diabetic AS.
ABCA1 and ABCG1 belong to cholesterol transporters
in human pancreatic β cells, that play an important role
in protecting against AS by facilitating cholesterol extracel-
lular efflux from macrophages or foam cells [16]. Moreover,
recent studies have found that the effect of ABCG1 on AS
lesion development in LDLR−/− mice depends on the stage
of AS, that is, ABCG1 is atheroprotective in early lesions.
As the lesions advance, ABCG1 enhances apoptosis and the
compensatory mechanism, thus promoting further AS pro-
gression [17]. In addition, ABCA1 high expression was
associated with plaque complexity and oxLDL high level in
plaques. ABCA1 mRNA and protein expressions exhibited
an increasing trend before AS formation. oxLDL induced
ABCA1 expression, and the foam cells induced by oxLDL
could also enhance ABCA1 expression [18]. Our study
found that mRNA expressions of ABCA1 and ABCG1 in
aortas of diabetic Balb/c mice were elevated in the CRP/E F G H
NEG Eotaxin Fasligand bFGF
NEG Eotaxin Fasligand bFGF
IL-1α IL-1β IL-12p40/p70 IL-12p70
IL-1α IL-1β IL-12p40/p70 IL-12p70
MCP-1 M-CSF MIG PF-4
MCP-1 M-CSF MIG PF-4
VEGF NEG NEG NEG
VEGF NEG NEG NEG
Figure 7 Effects of CRP/oxLDL/β2GPI on inflammatory cytokines in the aortas. Extracts of protein from the NC and diabetes animals were
added into each well of Protein chip. A laser scanner (Scan-array Gx, PerkinElmer) was used to read the signals for each spot. The relative fold
differences in the cytokine amount were determined by an analysis tool (Raybio, USA). A: Protein chip images. Red: positive control; black: bFGF;
yellow: IGF-II; pink: IL-1; blue: IL-9; green: PF-4; white: negative control. B: IL-1, IL-9, bFGF, IGF-II and PF-4 average relative optical density in the aortas.
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oxLDL/β2GPI complex to increase ABCA1 and ABCG1
mRNA expression may be one of the important mecha-
nisms of pro-AS.
Moreover, not only cholesterol metabolism is involved
in the pathological change of AS, lipoprotein receptors,Table 2 IL-1, IL-9, bFGF, IGF-II and PF-4 average relative
optical density in aortas
oxLDL β2GPI oxLDL/β2GPI CRP/oxLDL/β2GPI PBS
IL-1α 21904 21907 27224 32273 21904
bFGF 23628 33264 42119 47649 24564
IL-9 27224 29689 37154 42225 26869
IGF-II 32189 32689 37154 43219 32189
PF-4 60035 60535 65535 77560 47084especially scavenger receptors, participate in AS process
directly.
Scavenger receptor-B includes two subtypes, CD36 and
SR-BI, which ligands are oxLDL and HDL, respectively.
Combined with CD36, oxLDL, subsequently stimulates
macrophage infiltration and SMC migration and prolifera-
tion, leading to vascular endothelial cells apoptosis, ero-
sion of vessel walls, destroyed coagulation mechanism,
and finally macrophage apoptosis, resulting in AS plaques
[19]. CD36 inhibition of CRP/oxLDL/β2GPI may be a re-
sult of compensatory mechanism at the early stage of AS
lesion. On the other hand, SR-BI is the only membrane re-
ceptor that mediates the interaction between cells and
HDL, preventing free cholesterol from accumulating at
the artery walls, thus reducing AS incidence [20]. Lower-
ing SR-BI expression through the CRP/oxLDL/β2GPI
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in the macrophages and foam cell formation, both of
which may take part in the pro-AS process.
It is known that β2GPI interacts with oxLDL via 7-
ketocholesterol having an w-carboxyl acyl chain, produ-
cing stable and nondissociable oxLDL/β2GPI complexes
[5,21,22].
Once β2GPI binds with oxLDL, specific epitope of
oxLDL was covered, distrubing its binding with anti-
bodies, thus also ameliorating the pro-atherosclerosis of
oxLDL [23]. Furthermore, β2GPI decreased cellular ac-
cumulation of cholesterol via a reduction in cholesterol
influx and an increase in cholesterol efflux, suggesting
that β2GPI might play an important role in the preven-
tion of atherosclerosis [24], and that may explain β2GPI
and oxLDL/β2GPI made less lipid accumulation than
oxLDL. However, when oxLDL/β2GPI further interacts
with CRP through another site named oxPC [25], the
pro-AS function of CRP/oxLDL/β2GPI complex was en-
hanced as our results showed, maybe due to the strong
pro-inflammation function of CRP in AS of both cardio-
vascular and cerebrovascular diseases [26].
When refering to the signaling pathway potentially in-
volved in AS pathogenesis, hyperglycemia AS causes ac-
tivation of MAPK in the aortas of BALB/c mice. The
major members of MAPKs found in aortas include p38
MAPK and are most strongly activated by oxidative stress,
hyperglycemia and proinflammatory cytokines [27].
Our results demonstrated enhanced activation p38MAPK
and its upstream protein p-MKK3/6 with the treatment
of CRP/oxLDL/β2GPI complex in diabetic Balb/c mice.
Hence, the p38MAPK pathway activated by the CRP/
oxLDL/β2GPI complex may be the one of the key molecule
mechanisms of pro-AS.
The protein chip was also applied in the investigation
to quickly detect cytokines associated with AS develop-
ment. We found that the expression level of five cyto-
kines, namely, bFGF, IGF-II, IL-1α, IL-9, and PF-4 were
significantly elevated. The five specific cytokines were
expressed highest in the CRP/oxLDL/β2GPI group. All of
them are participating in the regulation of AS onset and
drive AS development through different ways [28-31],
which prove that the CRP/oxLDL/β2GPI complex in-
creases the inflammation level in diabetic Balb/c mice by
increasing pro-inflammatory cytokine expression, leading
to further AS development. However, the level of cyto-
kines with elevated expression needs further verification
by Western blot or enzyme-linked immunosorbent assay.
This study focused on the CRP/oxLDL/β2GPI com-
plex, and explored and compared its effects with those
of oxLDL, β2GPI, and oxLDL/β2GPI complexes on the
genesis and progression of diabetic atherosclerosis. After
the invention of the CRP/oxLDL/β2GPI complex, more
AS plaques and lesions were elicited in diabetic Balb/cmice, which indicated the importance of CRP/oxLDL/
β2GPI in the development of diabetic atherosclerosis
and provided new evidence that p38MAPK is a principal
regulator of inflammatory response.
Materials and methods
Reagents
oxLDL was purchased from XINYUANJIAHE Biotechnol-
ogy Co., Ltd, BeiJing, China. CRP (pro-557) was from Pro-
tein Specialists, Israel. β2GPI was extracted and purified
by TianJin Medical University Metabolic Diseases Hospital
and Novo Nordisk (Details refer to Supplementary). STZ
(s0130) were obtained from Sigma-Aldrich, USA. Anti-
β2GPI MAb (WB-CAL-1), anti- apoB-100 MAb (N2E10)
and anti-CRP Abs were gifts from professor Steven Krilis
the Department of Medicine,St. George Hospital Clinical
School, University of New South Wales, Sydney, Australia.
Rats anti-macrophage antibody (MAC, sc-101447),
mice anti-β-actin antibody, mice anti-phospho-MKK3/
MKK6 (9231s) antibody were from Santa Cruz Biotechnol-
ogy, Inc, USA. Mice anti-α-smooth muscle actin (SMA,
BM0002) antibody, rabbit anti-CD3 (BA0429) antibody
were purchased from Boster, Wuhan, China. Rabbit anti-
phospho-p38MAPK (9212) antibody was purchased from
Cell Signaling Technology, USA. Cytokine array kit (Mouse
angiogenesis antibody array G Series 1) was gained from
RayBiotech Inc, USA.
Animals
Eight-week old female Balb/c mice bought from Peking
University Laboratory Animal Center (BeiJing, China)
were housed in a temperature-controlled animal facility
under a 12 h light/dark cycle with food and water ad
libitum. Animal procedures were approved by the TianJin
Government Ethics Committees and were in accordance
with the Laboratory Animal Science Ethics Requirements
of TianJin Medical University. This research was in accor-
dance to the Guide for Laboratory Animal Management
and Application printed by China National Health Bureau.
Complex preparation and identification
The preparation for oxLDL/β2GPI complex was obtained
by incubating oxLDL (1 mg apolipoprotein B equivalent/
mL) and β2GPI (1 mg/mL) in the absence of CaCl2 at
37°C for 16 h. OxLDL/β2GPI (1 mg/mL of apoB equiva-
lent) was further incubated with CRP (0.1 mg/mL) in the
presence of 2 mM CaCl2 at 37°C for another 16 h to form
a nondissociable CRP/oxLDL/β2GPI complex. This pro-
cedure was performed as previously described [7].
ELISA for oxLDL/β2GPI complexes. This procedure
was performed as previously described [7]. Briefly, anti-
β2GPI MAb,WB-CAL-1, was adsorbed onto microtiter
plates by incubating at 8 mg/ml (dissolved in Hepes buffer,
50 ml/well) at 4°C over night. After blocking with Hepes
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with Hepes buffer containing 0.5% skim milk were added
to the wells (100 ml/well) to be incubated for 2 h. The
wells were then incubated with HRP-labeled anti-human
apoB-100 MAb (N2E10). Extensive washing between steps
was performed with Hepes buffer containing 0.05%
Tween20. Color was developed with tetramethylbendizine
and H2O2. The reaction was terminated, and optical den-
sity at 450 nm was measured.
ELISA for CRP/oxLDL complex. This procedure was
also performed as previously described [7]. Captured anti-
apoB-100 MAb,N2E10, was adsorbed onto microtiter
plates by incubating at 8 mg/ml (dissolved in Hepes buffer,
50 ml/well) at 4°C overnight. After blocking with 10 mM
Tris, 150 mM NaCl, 1.25 mM CaCl2, pH7.4, Tris buffer
containing 0.5% BSA, samples diluted 1:100 with Tris buf-
fer containing 0.2% BSA were added to each well and in-
cubated for 2 h. The wells were subsequently incubated
with HRP-labeled anti-CRP Abs for 1 h. Extensive washing
between steps was performed with Tris buffer containing
0.05% Tween 20. Further steps were performed as de-
scribed above for oxLDL/β2GPI complex.
Animal model
Mice were randomised into diabetes mellitus group (DM
group, n=120) and normal control group (NC group,
n=24) maintained on high-fat and sugar diet composed
of (by mg) 10% sugar, 10% lard, 5% yolk, 1% cholesterol,
and 0.2% bile salt and standard chow diet, respectively.
Each mouse remained on the assigned diet throughout
the whole experiment. After eight weeks, the DM group
was intraperitoneally injected with 80 mg/kg 2% STZ
three times for three days. The tail vein blood glucose
was measured 72 h after the injection, and those with
blood glucose ≥16.7 mmol/L were considered DM mice.
The NC group was simultaneously injected with sodium
citrate buffer. Two weeks later, the DM group was
treated with oxLDL 20 μg, β2GPI 20 μg, oxLDL/β2GPI
complex 40 μg, CRP/oxLDL/β2GPI complex 44 μg, and
PBS, after which they were randomly divided into oxLDL
group, β2GPI group, oxLDL/β2GPI group, CRP/oxLDL/
β2GPI group, and PBS group, respectively (each group
n=24). The same interventions were boosted four weeks
later. NC group were injected with PBS at the same time.
Body weight was assessed every week. After the injection
of STZ, blood glucose was monitored weekly. Four weeks
later, blood was obtained via retro-orbital plexus and then
sacrificed by cervical dislocation. Aortas were carefully
dissected from the iliac bifurcation to the aortic arch and
external fatty deposits were removed. Complete aortas
were then collected. Some were conserved in −80°C for
real-time PCR and Western blot, whereas the others were
fixed in 4% (w/v) paraformaldehyde for Sudan IV, H&E,
and IH staining.Plasma lipid level
Blood samples were centrifuged at 3500 rpm for 5 min
at room temperature. Plasma concentration of triglycer-
ides (TG) and total cholesterol (TC) were determined by
enzymatic colorimetric assays using an Automatic Bio-
chemical Analyzer (Hitachi Co., Japan).En face aorta analysis
The aortas were fixed in 4% (w/v) paraformaldehyde
overnight and longitudinally cut open under the micro-
scope, after which they were unfolded flat on the slide
with a coverslip on top. After rinsing in 70% (v/v) alco-
hol, the specimens were stained with Sudan IV solution
for 15 min, and then decolorised in 80% (v/v) alcohol for
20 min until the normal tissue turned white. Distilled
water was used to wash the tissues gently. Filter papers
were used to adsorb the liquid. Neutral resins blocked
the specimens. Pictures were taken using a PowerShot
S70 camera (Canon, Japan) connected to an IX51 micro-
scope (Olympus, Japan). Image analysis was performed with
Image Pro-Plus 6.0 (Media Cybernetics, Bethesda, MD).
The percentage of plaque coverage was also calculated.Histopathology
Paraffin-embedded aortas were serially sectioned at 5 μm
thickness, and then deparaffinated with dimethylbenzene
twice for 15 min and absolute ethyl alcohol dehydration
twice for 5 min, followed by ethanol dehydration, distilled
water washing, and haematoxylin staining for 5 min each.
Afterwards, water washing, 1% hydrochloric acid ethanol
differentiation, water washing, and 0.5% eosin staining for
1 min to 3 min were performed. Next, the aortas were
washed with distilled water, 80% ethanol, 95% ethanol, and
100% ethanol, and then transferred with dimethylbenzene
twice for 2 min and blocked with neutral resins. Slices were
examined by microscopy to evaluate the overall architec-
ture with attention to atherosclerotic changes, in addition
to any other histopathology alterations. Measurements of
intima thickness were normalised by the media thickness
at the thickest area of plaque by Image Pro-Plus 6.0.Immunohistochemistry
Paraffin-embedded slices were deparaffinated, dehydrated,
washed, and dried successively. After antigen retrieval and
blocking, primary antibodies were added (Mac 1:200 or α-
SMA 1:100 or CD3 1:100), and then incubated at 4°C
overnight. Biotinylated second antibody (1:200) was added
and washed with PBS, followed by a 20 min HRP-labelled
streptavidin incubation. Infiltrations of macrophages,
SMCs, and T cells in aortas were quantified as the per-
centage of the luminal surface covered by positive cells to
plaque area, as previously described [32].
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Primers for scavenger receptor B1 (SR-B1), scavenger re-
ceptor B (CD36), ATP binding cassette receptor D1
(ABCD1), ATP binding cassette receptor G1 (ABCG1),
and β-actin were designed according to the GenBank
database using Primer Express software. The primer se-
quences for SR-B1 were as follows: forward, 50TTTGGA
GTGGTAGTAAAAAGGGC-30 reverse 50−TGACATCAG
GGACTCAGAGTAG-30; for CD36, forward 50−GAACC
ACTGCTTTCAAAAACTGG-30, reverse 5≠−TGCTGTT
CTTTGCCACGTCA-30; for ABCA1, forward 50−AGTG
ATAATCAAAGTCAAAGGCACAC-30, reverse 50−AGC
AACTTGGCACTAGTAACTCTG-30; for ABCG1, for-
ward 50−TTCATCGTCCTGGGCATCTT-30, reverse 50−C
GGATTTTGTATCTGAGGACGAA-30, for β-actin, 50−T
GGAGAAGAGCTATGAGCTGCCTG-30, reverse 50−GT
GCCACCAGACAGCACTGTGTTG-30. Total RNA was
isolated using Trizol. Reverse transcription for comple-
mentary DNA synthesis and analysis were performed as
previously described [33]. The reaction system was then
prepared for amplification. Folds= 2 –ΔΔCt, ΔΔCt= (Ct1-
Ct2)-(Ct3-Ct4). Ct1 and Ct2 are critical cycle numbers of
the target gene and the β-actin in the DM group, respec-
tively; Ct3 and Ct4 stand for critical cycle numbers of the
target gene and the β-actin in group N, respectively.
Western blot
The aortas were dissolved and the concentration of pro-
tein was determined by the BCA reagents according to
the manufacturer's manual. We prepared 10% (w/v) so-
dium dodecyl sulfate polyacrylamide gel electrophoresis,
and then 50 μg protein, 3 μL l mol/L DTT, the same vol-
ume of 2× buffer, and enough TBE formed the loading
solutions. The initial voltage was 60 V, which changed to
80 V when the sample entered the separation gel. Pro-
tein was transferred to the nitrocellulose membrane for
2 h, and the membrane was successively incubated at
room temperature with 5% (w/v) bovine serum albumin
(BSA) in Tris-buffered saline with Tween 20 (TBST) for
1 h. The membranes were incubated overnight at 4°C
with anti-phospho-MKK 3/6, anti-phospho-p38 MAPK
antibody, and β-actin at a dilution of 1:1000 in TBST.
Membranes were washed with TBST 3 times for 10 min
each, and then incubated with a 1:1000 dilution of anti-
rabbit horseradish peroxidase antibody for 1 h in the dark.
During the end of incubation, the membrane was exten-
sively washed with TBST. The immunoreactive bands
were detected by ECL reagents, imaged, and analysed
using BandScan software.
Protein chip
The aortas were dissolved and the protein concentration
was determined by BCA reagents as above. Mouse angio-
genesis antibody array G Series 1 consists of 24 cytokineantibodies spotted in duplicates on a glass slide [34].
According to the manufacturer’s instructions, the glass
slide was assembled into an incubation chamber and dried
for 2 h. Samples were added into each well, incubated,
and blocked. Biotin-conjugated antibodies and fluorescent
dye-conjugated streptavidin were then added. The cham-
ber was covered with adhesion film and then incubated.
The slide was placed in a centrifuge full of wash buffer,
where it was gently shaken. It was then centrifuged at 4°C
and thoroughly dried. A laser scanner (Scan-array Gx,
PerkinElmer) was used to read the signals. For each spot,
the net density gray level was determined by subtracting
the background gray levels from the total raw density gray
levels. The relative fold differences in cytokine amount
were determined by an analysis tool (Raybio, USA), and
graphs were automatically generated.
Statistical analysis
SPSS18.0 software was used to analyse data. Comparisons
among groups were accomplished by one-way ANOVA
and Student Newman Keuls (SNK) Test was used for the
statistical analysis of any 2 groups. Results were presented
as mean ± SD (x ± S). Significance was considered when
P < 0.05, α=0.05.
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